[11C]Cyclopropyl-FLB 457: A PET radioligand for low densities of dopamine D2 receptors

Bioorganic and Medicinal Chemistry

Volumn 16, Issue 13, 2008, Pages 6467-6473

  Airaksinen, Anu J ^a,b   Nag, Sangram ^a   Finnema, Sjoerd J ^a   Mukherjee, Jogeshwar ^c   Chattopadhyay, Sankha ^c   Gulyás, Balázs ^a   Farde, Lars ^a   Halldin, Christer ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antagonist; Autoradiography; D2 receptor; Dopamine; PET

Indexed keywords

CYCLOPROPYLISOREMOXIPRIDE C 11; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; RACLOPRIDE; RADIOLIGAND; CARBON; ISOREMOXIPRIDE; LIGAND; PYRROLIDINE DERIVATIVE; SALICYLAMIDE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; CEREBELLUM; CONTROLLED STUDY; DRUG SYNTHESIS; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIPOPHILICITY; METHYLATION; MONKEY; NONHUMAN; OCCIPITAL CORTEX; PARIETAL LOBE; PLASMA PROTEIN BINDING; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; TEMPORAL CORTEX; THALAMUS; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; HAPLORHINI; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM;

MACACA FASCICULARIS;

ANIMALS; CARBON ISOTOPES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HAPLORHINI; HUMANS; LIGANDS; MOLECULAR STRUCTURE; POSITRON-EMISSION TOMOGRAPHY; PYRROLIDINES; RECEPTORS, DOPAMINE D2; SALICYLAMIDES;

EID: 44849089448     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2008.05.039     Document Type: Article

References (31)

1. Halldin C., Farde L., Högberg T., Mohell N., Hall H., Suhara T., Karlsson P., Nakashima Y., and Swahn C.-G. J. Nucl. Med. 36 (1995) 1275
2. Olsson H., Halldin C., Swahn C.-G., and Farde L. J. Cereb. Blood Flow Metab. 19 (1999) 1164
3. Okauchi T., Suhara T., Maeda J., Kawabe K., Obayashi S., and Suzuki K. Synapse 41 (2001) 87
4. Mukherjee J., Christian B.T., Dunigan K.A., Shi B., Narakyanan T.K., Satter M., and Mantil J. Synapse 46 (2002) 170
5. Mukherjee J., Shi B., Christian B.T., Chattopadhyay S., and Narayanan T.K. Bioorg. Med. Chem. 12 (2004) 95
6. Antonini A., Scwarz J., Oertel W.H., Pogarell O., and Leenders K.L. Mov. Disord. 12 (1997) 33
7. Thobois S., Jahanshahi M., Pinto S., Frackowiak R., and Limousin-Dowsey P. Neuroimage 23 (2004) 1
8. Hirvonen J., van Erp T.G.M., Huttunen J., Någren K., Huttunen M., Aalto S., Lönnqvist J., Kaprio J., Cannon T.D., and Hietala J. Psychiatry Res. Neuroimaging 146 (2006) 13
9. Talvik M., Nordström A.-L., Okubo Y., Olsson H., Borg J., Halldin C., and Farde L. Psychiatry Res. Neuroimaging 148 (2006) 165
10. Mayer J.H., McNeely H.E., Sagrati S., Boovariwala A., Martin K., Verhoeff N.P.L.G., Wilson A.A., and Houle S. Am J. Psychiatry 163 (2006) 1594
11. Kessler R.M., Whetsell W.O., Ansari M.S., Votaw J.R., de Paulis T., Clanton J.A., Schmidt D.E., Mason N.S., and Manning R.G. Brain Res. 609 (1993) 237
12. Schotte A., Janssen P.F.M., Gommeren W., Luyten W.H.M.L., van Gompel P., Lesage A.S., de Loore K., and Leysen J.E. Psychopharmacology 124 (1996) 57
13. Narendran R., Slifstein M., Guillin O., Hwang Y., Hwang D.-R., Scher E., Reeder S., Rabiner E., and Laruelle M. Synapse 60 (2006) 485
14. Seeman P., Wilson A., Gmeiner P., and Kapur S. Synapse 60 (2006) 205
15. Rabiner E.A., Raymond R., Diwan M., McCormick P., Wilson A.A., and Nobrega J. J. Nucl. Med. 48 Suppl. 2 (2007) 113P
16. Vogel M., Busse S., Freyberger H.J., and Grabe H.J. Med. Hypotheses 67 (2006) 354
17. Joyce J.N., and Millan M.J. Drug Discovery Today 10 (2005) 917
18. Heidbreder C.A., Gardner E.L., Zheng-Xiong X., Panayotis K.T., Mugnaini M., Hagan J.J., and Ashby Jr. C.R. Brain Res. Rev. 49 (2005) 77
19. Yang Z.-Y., and Mukherjee J. J. Med. Chem. Res. 9 (1999) 1
20. Sandell J., Langer O., Larsen P., Dollé F., Vaufrey F., Demphel S., Crouzel C., and Halldin C. J. Labelled Compd. Radiopharm. 43 (2000) 331
21. Lundkvist C., Sandell J., Någren K., Pike V.W., and Halldin C. J. Labelled Compd. Radiopharm. 41 (1998) 545
22. Olsson H., Halldin C., and Farde L. Neuroimage 22 (2004) 794
23. Asselin M.-C., Montgomery A.J., Grasby P.M., and Hume S.P. J. Cereb. Blood Flow Metab. 27 (2007) 378
24. Olsson H., and Farde L. Neuroimage 14 (2001) 936
25. Wilson A.A., Jin L., Garcia A., DaSilva J.N., and Houle S. Appl. Radiat. Isot. 54 (2001) 203
26. Hogberg T., de Paulis T., Johansson L., Kumar Y., Hall H., and Ogren S.O. J. Med. Chem. 33 (1990) 2305
27. Jewett D.M. Appl. Radiat. Isot. 43 (1992) 1383
28. Wienhard K., Dahlbom M., Eriksson L., Michel C., Bruckbauer T., Pietrzyk U., and Heiss W.D.T. J. Comput. Assist. Tomogr. 18 (1994) 110
29. Karlsson P., Farde L., Halldin C., Swahn C., Sedvall G., Foged C., Hansen K.T., and Skrumsager B. Psychopharmacology 113 (1993) 149
30. Roland P.E., and Zilles K. Trends Neurosci. 17 (1994) 458
31. Halldin C., Swan C.-G., Farde L., and Sedvall G. In: Comar D. (Ed). PET for Drug Development and Evaluation (1995), Kluwer, Dordrecht 55-65